Founded in 2021, Nucleate's New Haven chapter has supported 12 startups from Yale University, the University of Connecticut, and Jackson Labs, including Ascent Bio (A22), Cloverleaf Bio (A23), and EpiTET Therapeutics (A24). Nucleate New Haven works in collaboration with its sponsors, BioLabs New Haven, DTN Ventures, and Millipore Sigma, as well as key partners, Boehringer Ingelheim, Tsai CITY, and Yale Ventures.
PROGRAM DETAILS OUR ADVISORSHeraclitos Lefcochilos-Fogelquist
VP, Growth2024 COHORT
Nucleate's Activator forms pioneering biotech companies without taking equity.
Timeline and FAQ.
Deadline for US chapters is October 21st. Deadline for international chapters will vary. Please contact your local chapter to verify.